Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension

This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudina...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 72; no. 3; pp. 739 - 745
Main Authors Tomiyama, Hirofumi, Shiina, Kazuki, Vlachopoulos, Charalambos, Iwasaki, Yoichi, Matsumoto, Chisa, Kimura, Kazutaka, Fujii, Masatsune, Chikamori, Taishiro, Yamashina, Akira
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P<0.01), and elevation of the CRP (estimate=0.08×10, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.
AbstractList This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=-2.02, P<0.01), and elevation of the CRP (estimate=0.08×10-1, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10-2, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=-2.02, P<0.01), and elevation of the CRP (estimate=0.08×10-1, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10-2, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.
This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P<0.01), and elevation of the CRP (estimate=0.08×10, P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10, P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.
This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P =0.04), decrease of the estimated glomerular filtration rate (estimate=−2.02, P <0.01), and elevation of the CRP (estimate=0.08×10 −1 , P =0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10 −2 , P <0.01) and CRP (estimate=1.91, P =0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.
This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of hypertension (ie, increased arterial stiffness, renal dysfunction, and inflammation), and then examined whether these risk factors show longitudinal associations with the development of hypertension. In 3274 Japanese men without hypertension, the brachial-ankle pulse wave velocity, blood pressure, estimated glomerular filtration rate, and serum uric acid and CRP (C-reactive protein) levels were measured annually over an 8-year period. Of these, 474 subjects developed hypertension by the end of the study period. Mixed model linear regression analysis revealed a significant longitudinal association of hyperuricemia with increase of the brachial-ankle pulse wave velocity (estimate=5.50, P=0.04), decrease of the estimated glomerular filtration rate (estimate=-2.02, P<0.01), and elevation of the CRP (estimate=0.08×10 , P=0.02). Hyperuricemia at the study baseline was associated with a significant odds ratio for the development of hypertension by the end of the study period. After adjustments for covariates, the brachial-ankle pulse wave velocity (estimate=0.51×10 , P<0.01) and CRP (estimate=1.91, P=0.03), but not estimated glomerular filtration rate, were found to show independent longitudinal associations with the new onset of hypertension. In Japanese men without hypertension, hyperuricemia may have a longitudinal association with the development of hypertension, and increased arterials stiffness and inflammation may be involved in the risk of development of hypertension associated with hyperuricemia.
Author Iwasaki, Yoichi
Chikamori, Taishiro
Matsumoto, Chisa
Fujii, Masatsune
Tomiyama, Hirofumi
Shiina, Kazuki
Kimura, Kazutaka
Vlachopoulos, Charalambos
Yamashina, Akira
AuthorAffiliation From the Department of Cardiology and Division of Preemptive Medicine for Vascular Damage, Tokyo Medical University, Japan (H.T., K.S., Y.I., C.M., K.K., M.F., T.C., A.Y.) 1st Cardiology Department, Athens Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (C.V.)
AuthorAffiliation_xml – name: From the Department of Cardiology and Division of Preemptive Medicine for Vascular Damage, Tokyo Medical University, Japan (H.T., K.S., Y.I., C.M., K.K., M.F., T.C., A.Y.) 1st Cardiology Department, Athens Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (C.V.)
Author_xml – sequence: 1
  givenname: Hirofumi
  surname: Tomiyama
  fullname: Tomiyama, Hirofumi
  organization: From the Department of Cardiology and Division of Preemptive Medicine for Vascular Damage, Tokyo Medical University, Japan (H.T., K.S., Y.I., C.M., K.K., M.F., T.C., A.Y.) 1st Cardiology Department, Athens Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (C.V.)
– sequence: 2
  givenname: Kazuki
  surname: Shiina
  fullname: Shiina, Kazuki
– sequence: 3
  givenname: Charalambos
  surname: Vlachopoulos
  fullname: Vlachopoulos, Charalambos
– sequence: 4
  givenname: Yoichi
  surname: Iwasaki
  fullname: Iwasaki, Yoichi
– sequence: 5
  givenname: Chisa
  surname: Matsumoto
  fullname: Matsumoto, Chisa
– sequence: 6
  givenname: Kazutaka
  surname: Kimura
  fullname: Kimura, Kazutaka
– sequence: 7
  givenname: Masatsune
  surname: Fujii
  fullname: Fujii, Masatsune
– sequence: 8
  givenname: Taishiro
  surname: Chikamori
  fullname: Chikamori, Taishiro
– sequence: 9
  givenname: Akira
  surname: Yamashina
  fullname: Yamashina, Akira
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29987103$$D View this record in MEDLINE/PubMed
BookMark eNqNkU9v1DAQxS1U1G5LvwIKNy4B27ET-4DQqizsSlWL-kcqJ8tJJtTg2Fvb2arfHrPbvfTUw2ik0e-9Gc07RgfOO0DoA8GfCKnJ5-Wvn4urm8XF9eryYr6c56HIVUn8Bs0Ip6xkvK4O0AwTyUpJyN0ROo7xD8aEMdYcoiMqpWgIrmbo98ptvN3ACC4VfijmIUEw2hbXyQyDgxgL7fpi5Qarx1En411hXLF8WkOYgulgNLq8AqsT9MU32ID1673XFkrgYha9Q28HbSOcPvcTdPt9cXO2LM8vf6zO5udlx4TAJW_bpgIqW5JPF1y2nHUVNFSTXlQCWto3uGsEw0JjybnUtK9qSWhX16ITpK1O0Med7zr4hwliUqOJHVirHfgpKorrRghOuczo-2d0akfo1TqYUYcntX9OBr7ugC74GAMMqjNp-4IUtLGKYPU_DvUijjwUahtHdpAvHPZLXqP9stM-epsziX_t9AhB3YO26f4V-n-FdKXE
CitedBy_id crossref_primary_10_1096_fj_202402831R
crossref_primary_10_1016_j_pcad_2019_11_002
crossref_primary_10_1111_jch_13707
crossref_primary_10_1161_HYPERTENSIONAHA_118_11496
crossref_primary_10_18632_aging_102130
crossref_primary_10_1093_ajh_hpaa030
crossref_primary_10_1093_ajh_hpaa130
crossref_primary_10_1167_iovs_62_10_12
crossref_primary_10_3390_ijms19123699
crossref_primary_10_1093_ajh_hpaa050
crossref_primary_10_5551_jat_RV17041
crossref_primary_10_1186_s13075_022_02933_4
crossref_primary_10_1161_JAHA_119_013004
crossref_primary_10_3389_fendo_2023_1131566
crossref_primary_10_3390_ijms22084071
crossref_primary_10_5551_jat_63544
crossref_primary_10_2147_JIR_S446342
crossref_primary_10_1097_HCO_0000000000000626
crossref_primary_10_14712_18059694_2019_132
crossref_primary_10_2147_VHRM_S355410
crossref_primary_10_23736_S2724_5683_24_06494_9
crossref_primary_10_1016_j_esxm_2020_100319
crossref_primary_10_3390_medicina58030373
crossref_primary_10_3389_fendo_2023_1197628
crossref_primary_10_1155_2019_7545137
crossref_primary_10_1097_MD_0000000000032327
crossref_primary_10_3389_fphar_2020_582680
crossref_primary_10_2459_JCM_0000000000000855
crossref_primary_10_1097_MD_0000000000037713
crossref_primary_10_3389_fcvm_2023_1105464
crossref_primary_10_3390_ijms20215301
crossref_primary_10_1016_j_molmet_2022_101549
crossref_primary_10_1038_s41598_024_83034_x
crossref_primary_10_1161_HYPERTENSIONAHA_121_17584
crossref_primary_10_1038_s41440_019_0388_2
crossref_primary_10_1097_XCE_0000000000000300
crossref_primary_10_1038_s41440_020_0472_7
crossref_primary_10_3389_fphar_2020_00345
crossref_primary_10_3390_jcm11133779
crossref_primary_10_1038_s41440_023_01354_3
crossref_primary_10_1056_NEJMc2026125
crossref_primary_10_1136_bmjopen_2020_037842
crossref_primary_10_5551_jat_63099
crossref_primary_10_1055_a_1023_6710
crossref_primary_10_1038_s41440_022_00857_9
crossref_primary_10_1186_s12889_025_22064_0
crossref_primary_10_1186_s12944_020_01226_6
crossref_primary_10_12998_wjcc_v8_i11_2246
Cites_doi 10.1177/1358863X10382946
10.1038/nrrheum.2014.124
10.1053/j.ajkd.2017.12.009
10.1038/ng.2876
10.1186/ar2761
10.1001/2012.jama.10503
10.1136/annrheumdis-2012-201916
10.1136/heartjnl-2012-302535
10.1186/ar3552
10.1253/circj.CJ-09-0534
10.1001/jama.290.22.2945
10.1002/acr.20344
10.1161/JAHA.117.005729
10.1097/HJH.0b013e32834f6a1d
10.1159/000464260
10.1053/j.ajkd.2010.02.344
10.1161/01.HYP.0000028589.66335.AA
10.1136/bmj.f4262
10.1161/HYPERTENSIONAHA.116.08114
10.1093/clinchem/47.3.444
10.33549/physiolres.931917
10.1161/hy1101.092839
10.1038/nrneph.2013.248
10.1291/hypres.25.359
10.1161/JAHA.117.008175
10.1161/HYPERTENSIONAHA.117.10370
10.1371/journal.pone.0067370
10.1371/journal.pone.0114259
10.1681/ASN.2014070660
ContentType Journal Article
Copyright 2018 American Heart Association, Inc
Copyright_xml – notice: 2018 American Heart Association, Inc
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/HYPERTENSIONAHA.118.11390
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 745
ExternalDocumentID 29987103
10_1161_HYPERTENSIONAHA_118_11390
10.1161/HYPERTENSIONAHA.118.11390
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
18M
1J1
2WC
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BCGUY
BOYCO
BQLVK
C45
CS3
DIK
DIWNM
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JK3
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OB3
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OWBYB
OWV
OWW
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
YYM
ZFV
.3C
.55
.GJ
3O-
AAYXX
ADFPA
ADGHP
ADNKB
AFFNX
AHRYX
AJNYG
BS7
C1A
CITATION
DUNZO
FW0
H13
JF9
JG8
JK8
N4W
N~M
OCUKA
ODA
ORVUJ
OUVQU
OWU
OWX
P-K
R58
T8P
X7M
XXN
YHZ
YYP
ZGI
ZZMQN
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OLW
RHF
7X8
ID FETCH-LOGICAL-c4880-5bb73e29b1194859b54c3e72a1d838eb2d70c78408a09559a2d36912c668c81b3
ISSN 0194-911X
1524-4563
IngestDate Thu Jul 10 17:43:04 EDT 2025
Wed Feb 19 02:33:24 EST 2025
Thu Apr 24 22:52:37 EDT 2025
Tue Jul 01 01:44:55 EDT 2025
Fri May 16 03:49:59 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords blood pressure
hyperuricemia
risk factors
inflammation
hypertension
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4880-5bb73e29b1194859b54c3e72a1d838eb2d70c78408a09559a2d36912c668c81b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.118.11390
PMID 29987103
PQID 2067885259
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2067885259
pubmed_primary_29987103
crossref_citationtrail_10_1161_HYPERTENSIONAHA_118_11390
crossref_primary_10_1161_HYPERTENSIONAHA_118_11390
wolterskluwer_health_10_1161_HYPERTENSIONAHA_118_11390
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-09-01
PublicationDateYYYYMMDD 2018-09-01
PublicationDate_xml – month: 09
  year: 2018
  text: 2018-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 2018
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
29987106 - Hypertension. 2018 Sep;72(3):582-584
References_xml – ident: e_1_3_3_20_2
  doi: 10.1177/1358863X10382946
– ident: e_1_3_3_31_2
  doi: 10.1038/nrrheum.2014.124
– ident: e_1_3_3_7_2
  doi: 10.1053/j.ajkd.2017.12.009
– ident: e_1_3_3_8_2
  doi: 10.1038/ng.2876
– ident: e_1_3_3_25_2
  doi: 10.1186/ar2761
– ident: e_1_3_3_16_2
  doi: 10.1001/2012.jama.10503
– ident: e_1_3_3_27_2
  doi: 10.1136/annrheumdis-2012-201916
– ident: e_1_3_3_6_2
  doi: 10.1136/heartjnl-2012-302535
– ident: e_1_3_3_28_2
  doi: 10.1186/ar3552
– ident: e_1_3_3_19_2
  doi: 10.1253/circj.CJ-09-0534
– ident: e_1_3_3_18_2
  doi: 10.1001/jama.290.22.2945
– ident: e_1_3_3_2_2
  doi: 10.1002/acr.20344
– ident: e_1_3_3_9_2
  doi: 10.1161/JAHA.117.005729
– ident: e_1_3_3_17_2
  doi: 10.1097/HJH.0b013e32834f6a1d
– ident: e_1_3_3_5_2
  doi: 10.1159/000464260
– ident: e_1_3_3_14_2
  doi: 10.1053/j.ajkd.2010.02.344
– ident: e_1_3_3_24_2
  doi: 10.1161/01.HYP.0000028589.66335.AA
– ident: e_1_3_3_30_2
  doi: 10.1136/bmj.f4262
– ident: e_1_3_3_4_2
  doi: 10.1161/HYPERTENSIONAHA.116.08114
– ident: e_1_3_3_12_2
  doi: 10.1093/clinchem/47.3.444
– ident: e_1_3_3_21_2
  doi: 10.33549/physiolres.931917
– ident: e_1_3_3_23_2
  doi: 10.1161/hy1101.092839
– ident: e_1_3_3_22_2
  doi: 10.1038/nrneph.2013.248
– ident: e_1_3_3_11_2
  doi: 10.1291/hypres.25.359
– ident: e_1_3_3_10_2
  doi: 10.1161/JAHA.117.008175
– ident: e_1_3_3_13_2
– ident: e_1_3_3_26_2
  doi: 10.1161/HYPERTENSIONAHA.117.10370
– ident: e_1_3_3_15_2
  doi: 10.1371/journal.pone.0067370
– ident: e_1_3_3_3_2
  doi: 10.1371/journal.pone.0114259
– ident: e_1_3_3_29_2
  doi: 10.1681/ASN.2014070660
– reference: 29987106 - Hypertension. 2018 Sep;72(3):582-584
SSID ssj0014447
Score 2.4957097
Snippet This study analyzed repeated measurement data to clarify the longitudinal associations between hyperuricemia and the risk factors for the development of...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 739
SubjectTerms Adult
Ankle Brachial Index
Blood Pressure - physiology
C-Reactive Protein - analysis
Glomerular Filtration Rate - physiology
Humans
Hypertension - physiopathology
Hyperuricemia - physiopathology
Inflammation - physiopathology
Male
Middle Aged
Odds Ratio
Pulse Wave Analysis
Risk Factors
Uric Acid - blood
Vascular Stiffness - physiology
Title Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension
URI https://www.ncbi.nlm.nih.gov/pubmed/29987103
https://www.proquest.com/docview/2067885259
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwELbKkCYQQrwNypsyiW8oY4kdx_lYwVAG2gSiQ92nyHEcFq1NpjXRYH-DP8ydk2beVkTZl6iyajfNcznfnZ-7I-QNgy2FSe25ngLfBHYMjq9U7nIeSQoGrNIB5jvv7fP4gH2aBJPB4LfFWmrqdEudL80ruQmqMAa4YpbsfyDbLwoD8BnwhSsgDNeVMN4tQbmYgt_mPH-E9EyMgH-rizw3Oqxl--YAe5uiiOGNGFzPU1NMaFZI17DhdGazh0xwH79k2O0dbp0Ba4-jdfoBA_Et1Uj_3HrrRWFkBRfG1az4JWfGQI0LUPnNrOhjOkdFsUhIO2-O-_HvU2zgclI102q-IARI-ANp1Zv_u2dyLtt-24dVoY4KO3bhiZ6cVVvpAhJresEztAXyGhEULFGGUjRZrvY5qv348MsOOAH7uAuN4hEMC2xZ07YjvVJVe4VZt8htH3wPbIvx-evF0RRjrMvBb29onWx2i73761KXjZ5rnsxdcu-sQnLE_NjkRlgWzvgBud-5Js6olbOHZKDLR2R9ryNfPCY_LHFzqtxZiJvTi5sD4ubY4uYUpbNU3BxL3HAtW6yekIOPO-P3sdv16XAVqn83SNOQaj9KPQ9rDUVpwBTVoS-9TFChUz8Lt1Uo2LaQpuCh9DPKI89XnAsFbhPdIGtlVepnxIkUzWiKBMjIZyFWw6OZyAKwofOQsSwcErF4kInqithjL5VpYpxZ7iVXMIBBkRgMhsTvp560lVxWmbS5QCsBvYuHabLUVTNPsO2BEIEfREPytIWxXxZMPAGWOx0SfgnXpM1t_vfPPr_pxBfkzsV79pKs1aeNfgVWc52-NlL8B6v3vjg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Involvement+of+Arterial+Stiffness+and+Inflammation+in+Hyperuricemia-Related+Development+of+Hypertension&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Tomiyama%2C+Hirofumi&rft.au=Shiina%2C+Kazuki&rft.au=Vlachopoulos%2C+Charalambos&rft.au=Iwasaki%2C+Yoichi&rft.date=2018-09-01&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0194-911X&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.118.11390&rft.externalDocID=10.1161%2FHYPERTENSIONAHA.118.11390
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon